Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Outcome of Patients Receiving Extracorporeal Photopheresis for Steroid Resistant Acute and Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies

Mauricette Michallet, MD PhD, Mohamad Sobh, PharmD, Alexandre Deloire, CRA, Daniela Revesz, MD, Youcef Chelgoum, MD, Mohamed El-Hamri, CRA, Franck-Emmanuel Nicolini, MD PhD, Hélène Labussière, MD, Olivier Hequet, MD

Blood (2018) 132 (Supplement 1): 5720.

https://doi.org/10.1182/blood-2018-99-118206

Published: 2018

Journal Articles

Long-Term Outcome of Patients Receiving Extracorporeal Photopheresis for Acute and Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies: Results from an Observational Study on 106 Patients

Mauricette Michallet, MD PhD, Mohamad Sobh, Alexandre Deloire, CRA, Daniela Revesz, MD, Youcef Chelgoum, MD, Mohamed El-Hamri, CRA, Fiorenza Barraco, MD, Helene Labussiere-Wallet, MD, Franck Emmanuel Nicolini, MD PhD, Olivier Hequet, MD

Blood (2017) 130 (Supplement 1): 4504.

https://doi.org/10.1182/blood.V130.Suppl_1.4504.4504

Published: 2017

Journal Articles

Correlation between MRD and Chimerism Kinetics in CLL Patients after Myeloablative and Non-Myeloablative Allogeneic Hematopoïetic Stem Cell Transplantation.

Adriana Plesa, MD, Quoc-Hung Le, MD, Daniela Revesz, MD, Xavier Thomas, MD PhD, Sophie Ducastelle, MD, Franck E. Nicolini, MD PhD, Anne-Sophie Michallet, MD, Isabelle Mollet, Valerie Dubois, PhD, Melisa Clark, Charles Dumontet, MD PhD, Nicole Raus, Mauricette Michallet, MD PhD

Blood (2007) 110 (11): 5048.

https://doi.org/10.1182/blood.V110.11.5048.5048

Published: 2007

Journal Articles

Prognostic Index for Older Adult Patients with Newly Diagnosed Acute Myeloid Leukemia: The Edouard Herriot Hospital Experience.

Claudiu Plesa, MD, Quoc-Hung Le, MD, Youcef Chelghoum, MD, Mohamed Elhamri, PhD, Isabelle Tigaud, MD, Bruno Anglaret, MD, Sophie Ducastelle, MD, Marie-Claire Perrin, MD, Frank Nicolini, MD, Amine Belhabri, MD, Jacques Troncy, MD, Anne Thiebaut, MD, Daniela Revesz, MD, Eric Wattel, MD, Charles Dumontet, MD, Mauricette Michallet, MD, Xavier Thomas, MD

Blood (2007) 110 (11): 4352.

https://doi.org/10.1182/blood.V110.11.4352.4352

Published: 2007

Journal Articles

Impact of Infused Peripheral Blood Stem Cell Parameters (Total Nucleated Cells, CD34+ Cells, CD3+ Cells and CFU-GM) on Transplant Outcome after Reduced Intensity Allogeneic HSCT.

Mauricette Michallet, MD, PhD, Quoc-Hung Le, MD, Anne Thiebaut, MD, Sophie Ducastelle, MD, Nicole Raus, Daniela Revesz, MD, Jacques Troncy, MD, Youcef Chelgoum, MD, Jean-Paul Bourgeot, Philippe Dubost, Olivier Hequet, MD PhD, Franck E. Nicolini, MD PhD

Blood (2007) 110 (11): 3048.

https://doi.org/10.1182/blood.V110.11.3048.3048

Published: 2007

Journal Articles

High Response Rate and Improved Graft-Versus-Host Disease (GVHD) Following Bortezomib as Salvage Therapy after Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation (RIC allo-SCT) for Multiple Myeloma (MM).

Jean El-Cheikh, MD, Mauricette Michallet, MD, Arnon Nagler, MD, Hugues de Lavallade, MD, Frank E. Nicolini, MD, Avichai Shimoni, MD, Catherine Faucher, MD, Mohamad Sobh, PhD, Daniela Revesz, MD, Izhar Hardan, MD, Sabine Furst, MD, Didier Blaise, MD, Mohamad Mohty, MD, PhD

Blood (2007) 110 (11): 1080.

https://doi.org/10.1182/blood.V110.11.1080.1080

Published: 2007

Journal Articles

Gemtuzumab Ozogamicin (Mylotarg ® ) as Single Agent Treatment for Adult Patients with Acute Myeloid Leukemia (AML).

Xavier Thomas, Quoc-Hung Le, Emmanuelle Tavernier, Samira Mahmoudi, Youcef Chelghoum, Franck Nicolini, Anne Thiebaut, Jacques Troncy, Daniela Revesz, Mohamed Elhamri, Mauricette Michallet

Blood (2005) 106 (11): 4598.

https://doi.org/10.1182/blood.V106.11.4598.4598

Published: 2005

Journal Articles

Bortezomib Therapy for Multiple Myeloma in Relapse after Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation (RICT).

Sophie Ducastelle, MD, Daniela Revesz, MD, Jacques Troncy, MD, Samira Mahmoudi, MD, Xavier Thomas, MD, PhD, Anne Thiebaut, MD, Franck E. Nicolini, MD, PhD, Emmanuelle Tavernier, MD, Quoc-Hung Le, MD, Youssef Chelgoum, MD, Aline Praire, Mauricette Michallet, MD, PhD

Blood (2005) 106 (11): 5399.

https://doi.org/10.1182/blood.V106.11.5399.5399

Published: 2005

Journal Articles

Donor Lymphocyte Infusion Management and Impact on Transplant Outcome after Reduced Intensity Conditioning Allogeneic Transplantation.

Mauricette Michallet, MD, PhD, Quoc-Hung Le, MD, Anne-Sophie Michallet, MD, Anne Thiebaut, MD, Emannuelle Tavernier, MD, Hanadi Rafii, MD, Daniela Revesz, MD, Jacques Troncy, MD, Aline Praire, Elodie Gadolet, Valerie Dubois, PhD, Lucette Gebuhrer, MD, Olivier Hequet, MD, PhD, Jean-Paul Bourgeot, Franck E. Nicolini, MD, PhD

Blood (2004) 104 (11): 2305.

https://doi.org/10.1182/blood.V104.11.2305.2305

Published: 2004

Journal Articles

B-Cell Depletion and Prevention of Hemolysis in Allogeneic Peripheral Blood Stem Cell Transplantation with Minor ABO Incompatibility.

Emmanuelle Tavernier, MD, Anne Thiebaut, MD, Franck Nicolini, MD, PhD, Quoc Hung Le, MD, Xavier Thomas, MD, PhD, Youcef Chelghoum, MD, Daniela Revesz, MD, Olivier Hecquet, MD, PhD, Philippe Dubost, Jean-Paul Bourgeot, Mauricette Michallet, MD, PhD

Blood (2004) 104 (11): 5151.

https://doi.org/10.1182/blood.V104.11.5151.5151

Published: 2004

Journal Articles

Kinetics of Chimerism Conversion to Total Donor Profile: Impact on Transplant Outcome after Reduced Intensity Conditioning Allogeneic Transplantation.

Mauricette Michallet, MD PhD, Quoc-Hung Le, MD, Anne-Sophie Michallet, MD, Franck E. Nicolini, MD PhD, Anne Thiebaut, MD, Emmanuelle Tavernier, MD, Hanadi Rafii, MD, Samira Mahmoudi, MD, Daniela Revesz, MD, Aline Praire, Elodie Gadolet, Valerie Dubois, PhD, Lucette Gebuhrer, MD

Blood (2004) 104 (11): 1821.

https://doi.org/10.1182/blood.V104.11.1821.1821

Published: 2004

NARROW

Outcome of Patients Receiving Extracorporeal Photopheresis for Steroid Resistant Acute and Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies

Long-Term Outcome of Patients Receiving Extracorporeal Photopheresis for Acute and Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies: Results from an Observational Study on 106 Patients

Correlation between MRD and Chimerism Kinetics in CLL Patients after Myeloablative and Non-Myeloablative Allogeneic Hematopoïetic Stem Cell Transplantation.

Prognostic Index for Older Adult Patients with Newly Diagnosed Acute Myeloid Leukemia: The Edouard Herriot Hospital Experience.

Impact of Infused Peripheral Blood Stem Cell Parameters (Total Nucleated Cells, CD34+ Cells, CD3+ Cells and CFU-GM) on Transplant Outcome after Reduced Intensity Allogeneic HSCT.

High Response Rate and Improved Graft-Versus-Host Disease (GVHD) Following Bortezomib as Salvage Therapy after Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation (RIC allo-SCT) for Multiple Myeloma (MM).

Gemtuzumab Ozogamicin (Mylotarg ® ) as Single Agent Treatment for Adult Patients with Acute Myeloid Leukemia (AML).

Bortezomib Therapy for Multiple Myeloma in Relapse after Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation (RICT).

Donor Lymphocyte Infusion Management and Impact on Transplant Outcome after Reduced Intensity Conditioning Allogeneic Transplantation.

B-Cell Depletion and Prevention of Hemolysis in Allogeneic Peripheral Blood Stem Cell Transplantation with Minor ABO Incompatibility.

Kinetics of Chimerism Conversion to Total Donor Profile: Impact on Transplant Outcome after Reduced Intensity Conditioning Allogeneic Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only